Campbell Newman Asset Management Inc Corcept Therapeutics Inc Transaction History
Campbell Newman Asset Management Inc
- $1.17 Billion
- Q4 2024
A detailed history of Campbell Newman Asset Management Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Campbell Newman Asset Management Inc holds 49,127 shares of CORT stock, worth $2.72 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
49,127
Previous 49,374
0.5%
Holding current value
$2.72 Million
Previous $2.28 Million
8.36%
% of portfolio
0.21%
Previous 0.18%
Shares
26 transactions
Others Institutions Holding CORT
# of Institutions
350Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$915 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$553 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$457 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$360 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$211 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.92B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...